跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lastacaft - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lastacaft
Approved
STANDARD
Lastacaft
Allergan Sales, LLC
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
aa04506677626c7c
Company
Allergan Sales, LLC
Type
Standard
Approval Details
Approval Id
aa04506677626c7c
Drug Approval Philippines Name
Lastacaft
Product Name
Lastacaft
Registration Number
DR-XY43136
Brand Name
Lastacaft
Generic Name
Alcaftadine
Dosage Form
Sterile Ophthalmic Solution
Dosage Strength
2.5 mg/ mL (0.25%w/v)
Manufacturer
Allergan Sales, LLC
Importer
Zuellig Pharma Corporation
Distributor
Zuellig Pharma Corporation
Company Detail Path
/organization/allergan-sales-llc-jersey-city-new-jersey-united-states
Issuance Date
31 July 2023
Expiry Date
09 August 2028
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
aa04506677626c7c
Type
Standard
Back to Philippines FDA Approvals